Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital.

Published byVerawati Halim Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital."— Presentation transcript:

1 Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed.
Wireless, full-body pressure mapping on a human subject in a hospital bed. (A and B) Diagram and photographs of the locations of 29 sensors on the back side of the body. (C and D) Photograph of an angle-adjustable bed in a hospital, with dual-antenna setup for continuous pressure monitoring. (E) Photograph of a subject (27 years of age, male, 90 kg) lying on the bed in the supine position. (F) Corresponding results of pressure measurements averaged over the body region. Number of sensors for average arm, four; leg, four; shoulder, four; buttock, three; dorsum, four; lumbar, three. Error bar: SD, one set. (G and H) Photograph of a subject and pressure measurements for the supine angle of 60°. (I) Maps of pressure distributions across the body in supine position 0° after 1000, (J) 2000, and (K) 3000 s. Seungyong Han et al., Sci Transl Med 2018;10:eaan4950 Published by AAAS

Download ppt "Fig. 5 Wireless, full-body pressure mapping on a human subject in a hospital bed. Wireless, full-body pressure mapping on a human subject in a hospital."

Similar presentations

First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip by Robert Farra, Norman F. Sheppard, Laura McCabe, Robert M. Neer, James M. Anderson,

First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip by Robert Farra, Norman F. Sheppard, Laura McCabe, Robert M. Neer, James M. Anderson,
Fig. 1. TP is highly expressed in myeloma.

Fig. 1. TP is highly expressed in myeloma.
Examples of functional imaging biomarkers in two DCA responders

Examples of functional imaging biomarkers in two DCA responders
Fig. 5. Correlation between CD34+CD45RA−CD90+ cell dose, engraftment success, and onset of neutrophil/platelet recovery in nonhuman primates. Correlation.

Fig. 5. Correlation between CD34+CD45RA−CD90+ cell dose, engraftment success, and onset of neutrophil/platelet recovery in nonhuman primates. Correlation.
Fig. 3. Design of the MGA algorithm.

Fig. 3. Design of the MGA algorithm.
Fig. 1. [11C]Martinostat images of all subjects show high cortical binding and distinct gray-white matter differences. [11C]Martinostat images of all subjects.

Fig. 1. [11C]Martinostat images of all subjects show high cortical binding and distinct gray-white matter differences. [11C]Martinostat images of all subjects.
Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.

Fig. 2. Mutational signature exposures in Taiwan HCCs and summary of AA signature mutations. Mutational signature exposures in Taiwan HCCs and summary.
BET inhibition and depletion repress the expression of BRCA1 and RAD51

BET inhibition and depletion repress the expression of BRCA1 and RAD51
Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.

Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.
Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.

Fig. 8. Gene and protein changes in ALK-dependent STING pathways in human sepsis. Gene and protein changes in ALK-dependent STING pathways in human sepsis.
Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.

Fig. 3. Antimicrobial activity is detected in diverse strains of CoNS and not predictable at the species level. Antimicrobial activity is detected in diverse.
Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.

Fig. 5. Correlation of tail and long bone growth velocities with Cxm serum concentrations in mice. Correlation of tail and long bone growth velocities.
Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.

Fig. 4. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive and HBeAg-negative chimpanzees. Liver HBV mRNA paired-end sequencing reads in HBeAg-positive.
Fig. 4. Hydrogel particle size and gelation mechanism.

Fig. 4. Hydrogel particle size and gelation mechanism.
Fig. 4. Validation of MGA algorithm in individuals with SCI or stroke.

Fig. 4. Validation of MGA algorithm in individuals with SCI or stroke.
Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.

Fig. 5. Performance of the MGA to enable or enhance locomotor control after SCI. Performance of the MGA to enable or enhance locomotor control after SCI.
Fig. 4. Biomechanical properties of treated tibiae.

Fig. 4. Biomechanical properties of treated tibiae.
Fig. 1. Schematic representation of the MANO method.

Fig. 1. Schematic representation of the MANO method.
JQ1 directly represses the promoter activities of BRCA1 and RAD51

JQ1 directly represses the promoter activities of BRCA1 and RAD51
Fig. 3. 3RMR response to graded ischemia ex vivo.

Fig. 3. 3RMR response to graded ischemia ex vivo.

Similar presentations

Ads by Google